147 related articles for article (PubMed ID: 957135)
1. Comparative serum prednisone and prednisolone concentrations following prednisone or prednisolone administration to beagle dogs.
Colburn WA; Sibley CR; Buller RH
J Pharm Sci; 1976 Jul; 65(7):997-1001. PubMed ID: 957135
[TBL] [Abstract][Full Text] [Related]
2. Distribution and metabolism of prednisone in mice, dogs, and monkeys.
El Dareer SM; Struck RF; White VM; Mellett LB; Hill DL
Cancer Treat Rep; 1977 Oct; 61(7):1279-89. PubMed ID: 412589
[TBL] [Abstract][Full Text] [Related]
3. Development of radioimmunoassays for prednisone and prednisolone. Application to studies of hepatic metabolism of prednisone.
Schalm SW; Summerskill WH; Go VL
Mayo Clin Proc; 1976 Dec; 51(12):761-6. PubMed ID: 994553
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo availability of commercial prednisone tablets.
Sullivan TJ; Sakmar E; Albert KS; Blair DC; Wagner JG
J Pharm Sci; 1975 Oct; 64(10):1723-5. PubMed ID: 1102660
[TBL] [Abstract][Full Text] [Related]
5. Kinetics and interconversion of prednisolone and prednisone studied with new radioimmunogassays.
Meikle AW; Weed JA; Tyler FH
J Clin Endocrinol Metab; 1975 Oct; 41(4):717-21. PubMed ID: 1176582
[TBL] [Abstract][Full Text] [Related]
6. Relative bioavailability of prednisone and prednisolone in man.
Tse FL; Welling PG
J Pharm Pharmacol; 1979 Jul; 31(7):492-3. PubMed ID: 38330
[No Abstract] [Full Text] [Related]
7. Radioimmunoassay for prednisolone.
Colburn WA; Buller RH
Steroids; 1973 Jun; 21(6):833-46. PubMed ID: 4716628
[No Abstract] [Full Text] [Related]
8. Comparative serum prednisone and prednisolone concentrations following administration to patients with chronic active liver disease.
Uribe M; Summerskill WH; Go VL
Clin Pharmacokinet; 1982; 7(5):452-9. PubMed ID: 7140120
[TBL] [Abstract][Full Text] [Related]
9. Bioavailability and pharmacokinetics of prednisone in humans.
Disanto AR; Desante KA
J Pharm Sci; 1975 Jan; 64(1):109-12. PubMed ID: 1133681
[TBL] [Abstract][Full Text] [Related]
10. Impaired conversion of prednisone to prednisolone in patients with liver cirrhosis.
Madsbad S; Bjerregaard B; Henriksen JH; Juhl E; Kehlet H
Gut; 1980 Jan; 21(1):52-6. PubMed ID: 7364321
[TBL] [Abstract][Full Text] [Related]
11. Radioimmunoassay for prednisone.
Colburn WA
Steroids; 1974 Jul; 24(1):95-106. PubMed ID: 4858442
[No Abstract] [Full Text] [Related]
12. Corticosteroids in liver disease: studies on the biological conversion of prednisone to prednisolone and plasma protein binding.
Powell LW; Axelsen E
Gut; 1972 Sep; 13(9):690-6. PubMed ID: 4639403
[TBL] [Abstract][Full Text] [Related]
13. Removal of prednisone and prednisolone by plasma exchange.
Stigelman WH; Henry DH; Talbert RL; Townsend RJ
Clin Pharm; 1984; 3(4):402-7. PubMed ID: 6467876
[TBL] [Abstract][Full Text] [Related]
14. Prednisone for chronic active liver disease: pharmacokinetics, including conversion to prednisolone.
Schalm SW; Summerskill WH; Go VL
Gastroenterology; 1977 May; 72(5 Pt 1):910-3. PubMed ID: 849821
[TBL] [Abstract][Full Text] [Related]
15. Influence of body condition on plasma prednisolone and prednisone concentrations in clinically healthy cats after single oral dose administration.
Center SA; Randolph JF; Warner KL; Simpson KW; Rishniw M
Res Vet Sci; 2013 Aug; 95(1):225-30. PubMed ID: 23473553
[TBL] [Abstract][Full Text] [Related]
16. Effect of food on the bioavailability of prednisone.
Tembo AV; Sakmar E; Hallmark MR; Weidler DJ; Wagner JG
J Clin Pharmacol; 1976; 16(11-12):620-4. PubMed ID: 791973
[TBL] [Abstract][Full Text] [Related]
17. [Comparative serum pharmacokinetics of prednisone and prednisolone methylsulfobenzoate after oral administration].
Brion N; Pibarot ML; Atienza P; Robin P; Carbon C
Presse Med; 1988 Apr; 17(12):569-71. PubMed ID: 2967477
[TBL] [Abstract][Full Text] [Related]
18. Effect of liver function on the metabolism of prednisone and prednisolone in humans.
Renner E; Horber FF; Jost G; Frey BM; Frey FJ
Gastroenterology; 1986 Apr; 90(4):819-28. PubMed ID: 3512355
[TBL] [Abstract][Full Text] [Related]
19. Prednisone per os is likely to have limited efficacy in horses.
Peroni DL; Stanley S; Kollias-Baker C; Robinson NE
Equine Vet J; 2002 May; 34(3):283-7. PubMed ID: 12108748
[TBL] [Abstract][Full Text] [Related]
20. The dose-dependent systemic availability of prednisone: one reason for the reduced biological effect of alternate-day prednisone.
Frey FJ; Rüegsegger MK; Frey BM
Br J Clin Pharmacol; 1986 Feb; 21(2):183-9. PubMed ID: 3954934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
